Logo image of FLGC

FLORA GROWTH CORP (FLGC) Stock Fundamental Analysis

NASDAQ:FLGC - Nasdaq - CA3397642016 - Common Stock

0.9129  -0.03 (-2.88%)

Fundamental Rating

3

FLGC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 37 industry peers in the Personal Care Products industry. FLGC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FLGC has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

FLGC had negative earnings in the past year.
In the past year FLGC has reported a negative cash flow from operations.
FLGC had negative earnings in each of the past 5 years.
FLGC had a negative operating cash flow in each of the past 5 years.
FLGC Yearly Net Income VS EBIT VS OCF VS FCFFLGC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -10M -20M -30M -40M -50M

1.2 Ratios

FLGC's Return On Assets of -67.90% is on the low side compared to the rest of the industry. FLGC is outperformed by 88.89% of its industry peers.
FLGC has a worse Return On Equity (-467.86%) than 86.11% of its industry peers.
Industry RankSector Rank
ROA -67.9%
ROE -467.86%
ROIC N/A
ROA(3y)-110.33%
ROA(5y)-128.97%
ROE(3y)-336.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FLGC Yearly ROA, ROE, ROICFLGC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 2K 4K 6K

1.3 Margins

FLGC has a worse Gross Margin (20.81%) than 83.33% of its industry peers.
FLGC's Gross Margin has declined in the last couple of years.
FLGC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.44%
GM growth 5YN/A
FLGC Yearly Profit, Operating, Gross MarginsFLGC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -2K -4K -6K -8K -10K

4

2. Health

2.1 Basic Checks

FLGC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FLGC has more shares outstanding
Compared to 1 year ago, FLGC has a worse debt to assets ratio.
FLGC Yearly Shares OutstandingFLGC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2M 4M 6M 8M
FLGC Yearly Total Debt VS Total AssetsFLGC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -5.92, we must say that FLGC is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of FLGC (-5.92) is worse than 94.44% of its industry peers.
FLGC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.92
ROIC/WACCN/A
WACC8.88%
FLGC Yearly LT Debt VS Equity VS FCFFLGC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 1.02 indicates that FLGC should not have too much problems paying its short term obligations.
FLGC's Current ratio of 1.02 is on the low side compared to the rest of the industry. FLGC is outperformed by 72.22% of its industry peers.
A Quick Ratio of 0.64 indicates that FLGC may have some problems paying its short term obligations.
FLGC's Quick ratio of 0.64 is on the low side compared to the rest of the industry. FLGC is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.64
FLGC Yearly Current Assets VS Current LiabilitesFLGC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 10M 20M 30M 40M

4

3. Growth

3.1 Past

FLGC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.53%, which is quite impressive.
The Revenue has decreased by -8.84% in the past year.
The Revenue has been growing by 784.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)84.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-256.25%
Revenue 1Y (TTM)-8.84%
Revenue growth 3Y784.32%
Revenue growth 5YN/A
Sales Q2Q%-28.02%

3.2 Future

Based on estimates for the next years, FLGC will show a very strong growth in Earnings Per Share. The EPS will grow by 41.74% on average per year.
Based on estimates for the next years, FLGC will show a decrease in Revenue. The Revenue will decrease by -3.48% on average per year.
EPS Next Y89.85%
EPS Next 2Y41.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.49%
Revenue Next 2Y-3.48%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
FLGC Yearly Revenue VS EstimatesFLGC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
FLGC Yearly EPS VS EstimatesFLGC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 0 -2 -4 -6 -8 -10

4

4. Valuation

4.1 Price/Earnings Ratio

FLGC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 12.79, which indicates a correct valuation of FLGC.
FLGC's Price/Forward Earnings ratio is rather cheap when compared to the industry. FLGC is cheaper than 88.89% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of FLGC to the average of the S&P500 Index (24.44), we can say FLGC is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 12.79
FLGC Price Earnings VS Forward Price EarningsFLGC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FLGC Per share dataFLGC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as FLGC's earnings are expected to grow with 41.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.74%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

FLGC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FLORA GROWTH CORP

NASDAQ:FLGC (1/22/2025, 11:41:29 AM)

0.9129

-0.03 (-2.88%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)N/A N/A
Inst Owners3.27%
Inst Owner Change0%
Ins Owners15.97%
Ins Owner Change17.35%
Market Cap15.77M
Analysts82.5
Price Target4.08 (346.93%)
Short Float %5.61%
Short Ratio0.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-271.05%
Min EPS beat(2)-335.73%
Max EPS beat(2)-206.37%
EPS beat(4)0
Avg EPS beat(4)-404.19%
Min EPS beat(4)-1048.46%
Max EPS beat(4)-26.21%
EPS beat(8)2
Avg EPS beat(8)-385.03%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-26.46%
Min Revenue beat(2)-27.06%
Max Revenue beat(2)-25.86%
Revenue beat(4)1
Avg Revenue beat(4)-12.19%
Min Revenue beat(4)-27.06%
Max Revenue beat(4)6.7%
Revenue beat(8)2
Avg Revenue beat(8)-10.57%
Revenue beat(12)3
Avg Revenue beat(12)-6.08%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2300%
EPS NY rev (1m)0%
EPS NY rev (3m)-62.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-21.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.79
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 3.71
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.55
EYN/A
EPS(NY)0.07
Fwd EY7.82%
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS3.71
BVpS0.25
TBVpS-0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -67.9%
ROE -467.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.81%
FCFM N/A
ROA(3y)-110.33%
ROA(5y)-128.97%
ROE(3y)-336.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.44%
GM growth 5YN/A
F-Score3
Asset Turnover2.19
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 11.31%
Cap/Sales 0.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.64
Altman-Z -5.92
F-Score3
WACC8.88%
ROIC/WACCN/A
Cap/Depr(3y)283.87%
Cap/Depr(5y)305.47%
Cap/Sales(3y)16%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-256.25%
EPS Next Y89.85%
EPS Next 2Y41.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.84%
Revenue growth 3Y784.32%
Revenue growth 5YN/A
Sales Q2Q%-28.02%
Revenue Next Year-14.49%
Revenue Next 2Y-3.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y28.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y50.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.33%
OCF growth 3YN/A
OCF growth 5YN/A